Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | CASP1 | P29466 | 1/20 | 0.32 |
| ▸ | CASP7 | P55210 | 1/20 | 0.32 |
| ▸ | HBB | P68871 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27729531 | 0.82 | ESR1 (0.43) | ALDH1A1HIF1AHSD17B10CYP1B1CYP2A6 | |
| SCHEMBL28970846 | 0.80 | ESR1 (0.44) | ALDH1A1HIF1AHSD17B10CYP1B1CYP2A6 | |
| SCHEMBL28034253 | 0.79 | ESR1 (0.41) | ALDH1A1HIF1AHSD17B10CYP1B1CYP2A6 | |
| SCHEMBL11992419 | 0.74 | ESR1 (0.37) | ALDH1A1HIF1AHSD17B10CYP1B1CYP2A6 | |
| SCHEMBL11971451 | 0.73 | ALDH1A1 (0.39) | ALDH1A1HIF1AHSD17B10CYP1B1CYP3A4 | |
| SCHEMBL1869357 | 0.72 | ESR1 (0.45) | ALDH1A1HIF1AHSD17B10CYP3A4ALOX15 | |
| SCHEMBL11971436 | 0.71 | SOS1 (0.38) | ALDH1A1HIF1AHSD17B10CYP1B1CASP1 | |
| SCHEMBL5012382 | 0.70 | ALDH1A1 (0.44) | ALDH1A1HIF1AHSD17B10CYP1B1CYP2A6 | |
| SCHEMBL5013845 | 0.70 | ALDH1A1 (0.44) | ALDH1A1HIF1AHSD17B10CYP1B1CYP2A6 | |
| SCHEMBL5010132 | 0.70 | ALDH1A1 (0.44) | ALDH1A1HIF1AHSD17B10CYP1B1CYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9517977-B2 | Materials for electronic devices | MERCK PATENT GMBH (DE) | 2016-12-13 | — | — | US | disclosed |
| US-20120211701-A1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2012-08-23 | — | — | US | disclosed |
| WO-2011050888-A1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2011-05-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120211701-A1 | MATERIALS FOR ELECTRONIC DEVICES | XPOT, ETV6, ERCC1 | ALDH1A1 106/4885HIF1A 4048/4885HSD17B10 3009/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.